TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmaq AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
167,978
|
191,997
|
147,370 |
| Financial expenses |
4,784
|
1,246
|
7,602 |
| Earnings before taxes |
103,610
|
122,861
|
73,402 |
| Total assets |
421,500
|
355,433
|
269,320 |
| Current assets |
387,883
|
318,459
|
229,044 |
| Current liabilities |
40,870
|
41,422
|
37,104 |
| Equity capital |
376,989
|
313,286
|
232,132 |
| - share capital |
1,449
|
1,527
|
1,631 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.4%
|
88.1%
|
86.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
61.7%
|
64.0%
|
49.8% |
| Return on assets (ROA) |
25.7%
|
34.9%
|
30.1% |
| Current ratio |
949.1%
|
768.8%
|
617.3% |
| Return on equity (ROE) |
27.5%
|
39.2%
|
31.6% |
| Change turnover |
-14,208
|
53,991
|
31,052 |
| Change turnover % |
-8%
|
39%
|
27% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.